Brief: Bavarian Nordic Receives Health Canada Approval For Chikungunya Vaccine
29/06/2026 06:31
BRIEF-Bavarian Nordic Receives Health Canada Approval For Chikungunya Vaccine June 29 (Reuters) - Bavarian Nordic A/S BAVA.CO:
BAVARIAN NORDIC RECEIVES HEALTH CANADA APPROVAL FOR CHIKUNGUNYA VACCINE
VIMKUNYA NOW APPROVED IN CANADA, U.S., EU, UK, AND SWITZERLAND
Source text: ID:nGNE39l5W8
Further company coverage: BAVA.CO
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Bavarian Nordic A/S
See all newsBrief: Bavarian Nordic Completes First Tranche Of Share Buy-Back Program
Bavarian Nordic gets four-year contract for mpox and smallpox vaccine from UK government
Brief: Bavarian Nordic Awarded Multi-Year Vaccine Contract By UK Government
Bavarian Nordic donates 75,000 mpox vaccine doses to global emergency stockpile
Brief: Bavarian Nordic Donates To Global Mpox Emergency Stockpile